Illumina Stock Analysis (NASDAQ:ILMN)
Illumina Analysis Video
View Illumina stock analysis video. This is our ILMN analyst opinion covering the buy and sell arguments for ILMN stock.
Illumina, Inc. Stock Rating (3.7/5)
Our Illumina stock opinion is based on fundamentals of the company. This Illumina stock analysis is based on latest Q1 earnings for 2017. The stock price analysis takes into account a company's valuation metrics.
Should you buy ILMN stock?
- Illumina's average operating margin of 21.4% was exceptional.
- LTM Net margins were good at 30.7% for Illumina.
- Illumina's return on invested capital of 17.5% is good.
- The LTM ROE of 32.8% for Illumina is attractive.
- Illumina has a healthy FCF (Free Cash Flow) margin of 14.2%.
Should you sell ILMN stock?
- Illumina has a debt/equity ratio of 0.49, which is worse than the average in the Medical sector.
- The company has an operating cash flow which is 0.5 times the net income. This is not a healthy sign.
- The ILMN stock currently trades at a PE of 52, which is expensive, compared to the industry average of 24.4.